odronextamab
regeneron
['odronextamab', 'dlbcl', 'elm-2']
excellent presentation on the phase ii study elm-2 of odronextamab in patients with rr dlbcl by michelle poon #wil 
Haematologist interested in lymphomas, stem cell transplantation and CART cells. #CART #BMT #lymphomas #immunotherapy #WomenInMedicine. President  of EBMT